Literature DB >> 35579699

Factors for conversion risk of colorectal endoscopic submucosal dissection: a multicenter study.

Yuki Kamigaichi1, Shiro Oka2, Shinji Tanaka3, Shinji Nagata4, Masaki Kunihiro5, Toshio Kuwai6, Yuko Hiraga7, Akira Furudoi8, Seiji Onogawa9, Hideharu Okanobu10, Takeshi Mizumoto11, Tomohiro Miwata12, Shiro Okamoto13, Kenichi Yoshimura14, Kazuaki Chayama1.   

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) has become a widely accepted treatment method for colorectal tumors; however, there are some persistent problems. This multi-center study aimed to characterize the risk factors for incomplete resection and perforation in standardized colorectal ESD procedures.
METHODS: This study included 2423 consecutive patients who underwent ESD for 2592 colorectal tumors between August 2013 and December 2018 at 11 institutions (1 academic hospital and 10 affiliated hospitals) from the Hiroshima GI Endoscopy Research Group. We evaluated the risk factors for interruption, piecemeal resection, and perforation of standardized colorectal ESD in relation to clinicopathologic and endoscopic characteristics.
RESULTS: The incidences of interruption, piecemeal resection, and perforation were 0.7%, 2.9%, and 3.0%, respectively. Multivariate analysis identified the following risk factors for interruption: perforation during the procedure, deep submucosal invasion (> 1000 μm), poor scope operability, and severe submucosal fibrosis. The risk factors for piecemeal resection included poor scope operability, severe submucosal fibrosis, and procedure time (≥ 85 min). The risk factors for perforation during the procedure were severe submucosal fibrosis, poor scope operability, procedure time (≥ 85 min), and tumor size (≥ 40 mm). Independent risk factors for severe submucosal fibrosis included a history of biopsy and lesions located on the fold or flexure.
CONCLUSIONS: Severe submucosal fibrosis and poor scope operability are the common risk factors for interruption, piecemeal resection, and perforation in standardized colorectal ESD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Colorectal tumors; Endoscopic submucosal dissection; Interruption; Perforation; Piecemeal resection

Mesh:

Year:  2022        PMID: 35579699     DOI: 10.1007/s00464-022-09250-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  40 in total

1.  Mucosectomy in the colon with endoscopic submucosal dissection.

Authors:  H Yamamoto; N Yahagi; T Oyama
Journal:  Endoscopy       Date:  2005-08       Impact factor: 10.093

2.  Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization.

Authors:  Shinji Tanaka; Shiro Oka; Iwao Kaneko; Mayuko Hirata; Ritsuo Mouri; Hiroyuki Kanao; Shigeto Yoshida; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2007-07       Impact factor: 9.427

3.  Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan.

Authors:  Shiro Oka; Shinji Tanaka; Yutaka Saito; Hiroyasu Iishi; Shin-ei Kudo; Hiroaki Ikematsu; Masahiro Igarashi; Yusuke Saitoh; Yuji Inoue; Kiyonori Kobayashi; Takashi Hisabe; Osamu Tsuruta; Yasushi Sano; Hiroo Yamano; Seiji Shimizu; Naohisa Yahagi; Toshiaki Watanabe; Hisashi Nakamura; Takahiro Fujii; Hideki Ishikawa; Kenichi Sugihara
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

4.  Real-world learning curve analysis of colorectal endoscopic submucosal dissection: a large multicenter study.

Authors:  Kazuki Boda; Shiro Oka; Shinji Tanaka; Shinji Nagata; Masaki Kunihiro; Toshio Kuwai; Yuko Hiraga; Akira Furudoi; Koichi Nakadoi; Hideharu Okanobu; Tomohiro Miwata; Shiro Okamoto; Kazuaki Chayama
Journal:  Surg Endosc       Date:  2019-09-03       Impact factor: 4.584

5.  Current status in the occurrence of postoperative bleeding, perforation and residual/local recurrence during colonoscopic treatment in Japan.

Authors:  Shiro Oka; Shinji Tanaka; Hiroyuki Kanao; Hideki Ishikawa; Toshiaki Watanabe; Masahiro Igarashi; Yutaka Saito; Hiroaki Ikematsu; Kiyonori Kobayashi; Yuji Inoue; Naohisa Yahagi; Sumio Tsuda; Seiji Simizu; Hiroyasu Iishi; Hiroo Yamano; Shin-Ei Kudo; Osamu Tsuruta; Satoshi Tamura; Yusuke Saito; Eisai Cho; Takahiro Fujii; Yasushi Sano; Hisashi Nakamura; Kenichi Sugihara; Tetsuichiro Muto
Journal:  Dig Endosc       Date:  2010-10       Impact factor: 7.559

6.  The efficacy and safety of prophylactic closure for a large mucosal defect after colorectal endoscopic submucosal dissection.

Authors:  Shintaro Fujihara; Hirohito Mori; Hideki Kobara; Noriko Nishiyama; Mitsuyoshi Kobayashi; Kazi Rafiq; Tsutomu Masaki
Journal:  Oncol Rep       Date:  2013-05-14       Impact factor: 3.906

7.  Factors predicting adverse events associated with therapeutic colonoscopy for colorectal neoplasia: a retrospective nationwide study in Japan.

Authors:  Ryota Niikura; Hideo Yasunaga; Atsuo Yamada; Hiroki Matsui; Kiyohide Fushimi; Yoshihiro Hirata; Kazuhiko Koike
Journal:  Gastrointest Endosc       Date:  2016-05-14       Impact factor: 9.427

8.  Differences in Clinical Course of Intraprocedural and Delayed Perforation Caused by Endoscopic Submucosal Dissection for Colorectal Neoplasms: A Retrospective Study.

Authors:  Taro Iwatsubo; Yoji Takeuchi; Yasushi Yamasaki; Kentaro Nakagawa; Masamichi Arao; Masayasu Ohmori; Hiroyoshi Iwagami; Kenshi Matsuno; Shuntaro Inoue; Hiroko Nakahira; Noriko Matsuura; Satoki Shichijo; Akira Maekawa; Takashi Kanesaka; Sachiko Yamamoto; Koji Higashino; Noriya Uedo; Ryu Ishihara
Journal:  Dig Dis       Date:  2018-09-18       Impact factor: 2.404

9.  Use of anticoagulants increases risk of bleeding after colorectal endoscopic submucosal dissection.

Authors:  Ken Yamashita; Shiro Oka; Shinji Tanaka; Kazuki Boda; Daiki Hirano; Kyoku Sumimoto; Takeshi Mizumoto; Yuki Ninomiya; Yuzuru Tamaru; Kenjiro Shigita; Nana Hayashi; Yoji Sanomura; Kazuaki Chayama
Journal:  Endosc Int Open       Date:  2018-07-04

10.  Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer.

Authors:  Yoji Sanomura; Shiro Oka; Shinji Tanaka; Norifumi Numata; Makoto Higashiyama; Hiroyuki Kanao; Shigeto Yoshida; Yoshitaka Ueno; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2013-10-19       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.